Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Anus Neoplasms (Phase 2)

Bile Duct Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoid Tumor (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Ductal (Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Cholangiocarcinoma (Phase 2)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Esophageal Neoplasms (Phase 3)

Fallopian Tube Neoplasms (Phase 3)

Gastrointestinal Neoplasms (Phase 4)

Head and Neck Neoplasms (Phase 2)

Liver Neoplasms (Phase 3)

Lung Neoplasms (Phase 3)

Microsatellite Instability (Phase 2)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 1)

Neuroendocrine Tumors (Phase 3)

Neurotoxicity Syndromes (Phase 4)

Ovarian Neoplasms (Phase 3)

Pancreatic Neoplasms (Phase 3)

Prostatic Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 3)

Thromboembolism (Phase 3)

Urinary Bladder Neoplasms (Phase 2)